---
title: "AstraZeneca Asthma Drug Fails COPD Study for a Second Time"
date: 2025-09-17T06:18:13+08:00
categories: ["finance"]
tags: ["LSE:AZN"]
summary: "AstraZeneca Plc’s Fasenra failed to meet its goal in a late-stage trial of patients with chronic obstructive pulmonary disease for a second time, a blow to the drugmaker’s efforts to expand the market"
source_url: "https://www.bloomberg.com/news/articles/2025-09-17/astrazeneca-asthma-drug-fails-copd-study-for-a-second-time"
---

AstraZeneca Plc’s Fasenra failed to meet its goal in a late-stage trial of patients with chronic obstructive pulmonary disease for a second time, a blow to the drugmaker’s efforts to expand the market for the asthma treatment.

---

*来源: [原文链接](https://www.bloomberg.com/news/articles/2025-09-17/astrazeneca-asthma-drug-fails-copd-study-for-a-second-time)*
